U.S. Food and Drug Administration - CDRH Mobile
Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule

PDF Printer VersionGuidance for Industry and FDA Staff - Procedures for Renewal and Amendment of Certain Laser Light Show Variances (Laser Notice 55)

 

Document issued on: September 25, 2007

For questions regarding this document contact L. Dale Smith at 240-276-3332.

CDRH

U.S. Department of Health and Human Services
Food and Drug Administration
Center for Devices and Radiological Health

Electronic Products Branch
Division of Mammography Quality and Radiation Programs
Office of Communication, Education, and Radiation Programs


Preface

Public Comment

Written comments and suggestions may be submitted at any time for Agency consideration to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD, 20852. When submitting comments, please refer to the exact title of this guidance document. Comments may not be acted upon by the Agency until the document is next revised or updated.

Additional Copies

Additional copies are available from the Internet at: http://www.fda.gov/cdrh/ocer/guidance/1639.html. You may also send an e-mail request to dsmica@fda.hhs.gov to receive an electronic copy of the guidance or send a fax request to 240-276-3151 to receive a hard copy. Please use the document number (1639) to identify the guidance you are requesting.


Contains Nonbinding Recommendations

 

Guidance for Industry and FDA Staff

Procedures for Renewal and Amendment of Certain Laser Light Show Variances
(Laser Notice 55)

This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance.

Introduction

Under current radiological health regulations, the Center for Devices and Radiological Health (CDRH) may grant manufacturers of electronic products variances from requirements of the laser product performance standard subject to any conditions necessary to protect the public health and safety (21 CFR 1010.4). FDA also may amend or withdraw a variance for justified reasons (21 CFR 1010.4(c)(2)). This guidance provides CDRH's explanation of our decision to amend specified laser light show variances by changing their termination dates and the renewal process for certain laser light show variances currently in effect. CDRH has determined that the variance amendments described below are justified by 21 CFR 1010.4(a)(2). Affected variances will continue to provide suitable means for assuring radiation safety or protection. Notification of the amendment will be provided to affected variance holders by individually addressed letters.

FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.

The Least Burdensome Approach

We believe we should consider the least burdensome approach in all areas of medical device and electronic product regulation. This guidance reflects our careful review of the relevant scientific and legal requirements and what we believe is the least burdensome way for you to comply with those requirements. However, if you believe that an alternative approach would be less burdensome, please contact us so we can consider your point of view. You may send your written comments to the contact person listed in the preface to this guidance or to the CDRH Ombudsman. Comprehensive information on CDRH's Ombudsman, including ways to contact him, can be found on the Internet at http://www.fda.gov/cdrh/ombudsman/ .

1. Issue

All manufacturers of demonstration laser products, which includes all laser light shows and laser projection systems used in light shows, must comply with the requirements specified in Title 21 of the Code of Federal Regulations (21 CFR), Sections 1040.10 and 1040.11. The laser standard limits demonstration laser products to laser emission levels not in excess of the limits of Class IIIa in 21 CFR 1040.11(c). However, many laser light shows are intended to be produced in large spaces, requiring the use of laser emission levels of Class IIIb or Class IV to produce the desired visual effects. Class IIIb or Class IV shows may be produced only when there is a variance approved by CDRH in accordance with 21 CFR 1010.4 permitting the use of lasers exceeding the Class IIIa demonstration laser product limit. CDRH believes that the variance process is a necessary and appropriate means to ensure public health and safety when high power laser beams are used in entertainment and display. Variance renewals have become routine and unnecessarily burdensome when there are no significant changes from an existing approved variance. Therefore, CDRH is now modifying the variance renewal and amendment processes to improve the efficiency of the process as follows:

These modifications in accordance with 21 CFR 1010.4(c)(2) will reduce the regulatory burden on manufacturers of laser light shows without compromising the public health.

2. Guidance

What laser light show variances are affected by this guidance?

What changes are being made to the amendment process and to current variances?

Manufacturers of Class IIIb and IV laser light shows and/or projection systems, who currently have approved variances and meet all of the conditions given above, will have their variance amended as follows.

What conditions apply to these changes?

How will affected variances be amended?

Each current variance holder will be notified by a letter in accordance with 21 CFR 1010.4(c)(1) that its variance has been amended in accordance with 21 CFR 1010.4(c)(2). The notification will include the amendment specifications and will have this Laser Notice (Laser Notice 55) attached.

What laser light show variances are NOT affected by this guidance?

Variances for projection systems and laser light shows intended to produce audience scanning or visible effects using invisible laser emissions, such as fluorescence or plasma breakdown, are not subject to this guidance. Such projectors and light show effects produced in excess of the Class I limits must be specifically approved by CDRH.

Variances requesting additional types of effects to be employed, additional location types where shows will be presented, or deviations from the normal clearance or other conditions are not subject to this guidance.

What requirements must continue to be met for all laser light show and projector products?

Manufacturers must continue to meet requirements for laser light shows and projectors, including:

Can the Center revoke a variance?

Yes. CDRH may withdraw any variance if necessary to enforce the Electronic Product Radiation Control Provisions of the Federal Food, Drug, and Cosmetic Act and applicable regulations. Such action may be appropriate if CDRH has reason to believe a manufacturer is creating a public heath or safety hazard by not complying with applicable requirements and the specific conditions of their variance.

3. Getting More Information

You can get more information about our requirements for lasers from our electronic product radiation control web page at http://www.fda.gov/cdrh/radhealth/products/lasers.html .

If you have questions about this guidance, contact L. Dale Smith, CDRH Office of Communication, Education, and Radiation Programs (HFZ-240), 9200 Corporate Boulevard, Rockville, MD 20850 or l.smith@fda.hhs.gov.

Updated September 27, 2007

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH